Quibim
The AI engine Fit Assessment
BetaQuibim is a leader in medical imaging analysis, utilizing AI to enhance the detection of diseases and track treatment efficacy through quantitative imaging biomarkers. Their platform integrates multi-omics data and advanced algorithms to improve patient outcomes in various medical fields, including oncology and immunology.
Blurb
Quibim is a radiomics company specializing in quantitative imaging of biomarkers and medical applications in precision medicine.
HQ Location
Valencia (Spain)
Founded
2012
Employees
51 - 200
Total funding raised
$69.59M
Funding Status
Series A, $50.00M, January 28, 2025
Subspaces
- Biomarker Identification
At Quibim, we design pioneering tools that unlock imaging data to improve patient outcomes. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers.